Oxandrolone steroid use and impaired coagulation.
Koller
Elizabeth A
EA
Wei
Xiaoxiong
X
Johnson
Timothy E
TE
D000369:Aged, 80 and over; D045930:Anabolic Agents / Q000009:adverse effects*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006474:Hemorrhagic Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D019934:International Normalized Ratio; D010074:Oxandrolone / Q000009:adverse effects*; D016896:Treatment Outcome; D010837:Vitamin K 1 / Q000627:therapeutic use
D045930:Anabolic Agents; D000933:Antifibrinolytic Agents; D010074:Oxandrolone; D010837:Vitamin K 1